0001237899-20-000037.txt : 20200831
0001237899-20-000037.hdr.sgml : 20200831
20200831163500
ACCESSION NUMBER: 0001237899-20-000037
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200828
FILED AS OF DATE: 20200831
DATE AS OF CHANGE: 20200831
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: POON CHRISTINE A
CENTRAL INDEX KEY: 0001189014
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 201151917
MAIL ADDRESS:
STREET 1: C/O JOHNSON & JOHNSON
STREET 2: ONE JOHNSON PLAZA
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-08-28
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001189014
POON CHRISTINE A
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
Common Stock
2020-08-28
4
M
0
15000
33.42
A
16433
D
Common Stock
2020-08-28
4
M
0
25000
25.45
A
41433
D
Common Stock
2020-08-28
4
S
0
177
598.91
D
41256
D
Common Stock
2020-08-28
4
S
0
5730
599.67
D
35526
D
Common Stock
2020-08-28
4
S
0
12490
600.44
D
23036
D
Common Stock
2020-08-28
4
S
0
8011
601.53
D
15025
D
Common Stock
2020-08-28
4
S
0
12899
602.39
D
2126
D
Common Stock
2020-08-28
4
S
0
693
603.2
D
1433
D
Non-Qualified Stock Option (right to buy)
25.45
2020-08-28
4
M
0
25000
0.0
D
2020-11-12
Common Stock
25000
0
D
Non-Qualified Stock Option (right to buy)
33.42
2020-08-28
4
M
0
15000
0.0
D
2021-01-03
Common Stock
15000
0
D
Represents volume-weighted average price of sales of 177 shares of Company stock on August 28, 2020 at prices ranging from $598.90 to $598.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2020 at each separate price.
Represents volume-weighted average price of sales of 5,730 shares of Company stock on August 28, 2020 at prices ranging from $599.00 to $599.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2020 at each separate price.
Represents volume-weighted average price of sales of 12,490 shares of Company stock on August 28, 2020 at prices ranging from $600.00 to $600.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2020 at each separate price.
Represents volume-weighted average price of sales of 8,011 shares of Company stock on August 28, 2020 at prices ranging from $601.00 to $601.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2020 at each separate price.
Represents volume-weighted average price of sales of 12,899 shares of Company stock on August 28, 2020 at prices ranging from $602.00 to $602.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2020 at each separate price.
Represents volume-weighted average price of sales of 693 shares of Company stock on August 28, 2020 at prices ranging from $603.00 to $603.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2020 at each separate price.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
/s/**Christine A. Poon
2020-08-31